LUMACAFTOR/IVACAFTOR: REAL WORLD EXPERIENCE IN A CF CENTER

被引：0
|
作者：
Anstead, M. [1 ]
Tupayachi, G. [2 ]
Murphy, D. [3 ]
Autry, E. [3 ]
Bulkley, V [1 ]
Kuhn, R. [3 ]
机构：
[1] Univ KY, Pediat, Lexington, KY USA
[2] Univ Kentucky, Internal Med, Lexington, KY USA
[3] Univ Kentucky, Sch Pharm, Lexington, KY USA
来源：
PEDIATRIC PULMONOLOGY | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
290
引用
收藏
页码：302 / 302
页数：1
相关论文
共 50 条
  • [1] EXPERIENCE OF A LARGE ACADEMIC CF CENTER WITH LUMACAFTOR/IVACAFTOR
    Walker, S. D.
    Henry, B.
    Sueblinvong, V
    Hunt, W. R.
    [J]. PEDIATRIC PULMONOLOGY, 2016, 51 : 302 - 302
  • [2] REAL WORLD EXPERIENCE OF LUMACAFTOR-IVACAFTOR AT AN URBAN CYSTIC FIBROSIS CENTER
    Ahmad, D.
    Patel, M.
    Mills, N.
    Stephen, M. J.
    [J]. PEDIATRIC PULMONOLOGY, 2016, 51 : 205 - 205
  • [3] RATES OF TREATMENT DISCONTINUATION FOLLOWING THE INITIATION OF LUMACAFTOR-IVACAFTOR IN ADULTS WITH CF: A SINGLE CENTER EXPERIENCE
    Sergeev, V
    Flores, E.
    Kerr, J.
    Su, V
    Wilcox, P. G.
    Quon, B. S.
    [J]. PEDIATRIC PULMONOLOGY, 2018, 53 : 240 - 241
  • [4] IVACAFTOR IN THE REAL WORLD - EARLY EXPERIENCE IN A LARGE ADULT CF CENTRE
    Spencer-Clegg, E.
    Sapina-Vivo, R.
    Cullen, D.
    Lloyd, E.
    Walshaw, M. J.
    [J]. PEDIATRIC PULMONOLOGY, 2013, 48 : 287 - 287
  • [5] EFFECT OF LUMACAFTOR / IVACAFTOR ON THE PHARMACOKINETICS OF IBUPROFEN IN CF
    Roesch, E.
    Lee, J.
    Konstan, M.
    [J]. PEDIATRIC PULMONOLOGY, 2017, 52 : S297 - S297
  • [6] PRACTITIONER DUE DILIGENCE: REAL-WORLD LUMACAFTOR/IVACAFTOR USE
    Middleton, E. A.
    McCoy, K. S.
    Novak, K. J.
    Gemma, S.
    Pape, C.
    Rice, A.
    Sakellaris, K. T.
    Kotha, K.
    [J]. PEDIATRIC PULMONOLOGY, 2017, 52 : S315 - S316
  • [7] EFFECT OF IVACAFTOR/LUMACAFTOR TREATMENT ON CF NEUTROPHIL FUNCTION
    Pohl, K.
    Bratcher, P. E.
    Malcolm, K. C.
    Nick, J. A.
    [J]. PEDIATRIC PULMONOLOGY, 2016, 51 : 301 - 301
  • [8] "REAL WORLD" IMPACT OF CFTR MODULATORS (LUMACAFTOR/IVACAFTOR AND TEZACAFTOR/IVACAFTOR) ON LONG-TERM PATIENT OUTCOMES
    Mermis, J.
    Polineni, D.
    He, J.
    [J]. PEDIATRIC PULMONOLOGY, 2019, 54 : S350 - S351
  • [9] Real World Assessment of Patients with Cystic Fibrosis Treated with Lumacaftor-Ivacaftor and Transitioned to Tezacaftor-Ivacaftor
    Christmas, A.
    O'Hagan, A. R.
    Morton, R. L.
    Eid, N. S.
    Bickel, S. G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [10] CFTR EFFECTS OF ORAL SILDENAFIL IN COMBINATION WITH LUMACAFTOR/IVACAFTOR IN ADULTS WITH CF
    Hunt, K.
    St Clair, C.
    Curran-Everett, D.
    Solomon, G. M.
    Saavedra, M. T.
    Nick, J. A.
    Nichols, D. P.
    Taylor-Cousar, J. L.
    [J]. PEDIATRIC PULMONOLOGY, 2017, 52 : S322 - S322
12345